Relation of serum uric acid to mortality and ischemic heart disease

American Journal of Epidemiology

Volumn 142, Issue 7, 1995, Pages 637-644

  Freedman, David S ^a   Williamson, David F ^a   Gunter, Elaine W ^b   Byers, Tim ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Cohort studies; ; Coronary disease; ; Uric acid.

Indexed keywords

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PREDICTION; PURINE METABOLISM; URIC ACID BLOOD LEVEL;

ADULT; AGED; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; UNITED STATES; URIC ACID;

EID: 0028913891     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117479     Document Type: Article

References (38)

1. Gertler MM, Gam SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease Ann Intern Med 1951;34:1421-31.
2. Persky VW, Dyer AR, Idris-Soven E, et al. Uric acid: a risk factor for coronary heart disease? Circulation 1979;59: 969-77.
3. Beard JT. Serum uric acid and coronary heart disease. Am Heart J 1983, 106:397-400.
4. Emmerson BT. Atherosclerosis and urate metabolism. Aust N Z J Med 1979;9:451-4.
5. The Hypertension Detection and Follow-up Program Cooperative Research Group. Mortality findings for stepped-care and referred-care participants in the Hypertension Detection and Follow-up Program, stratified by other risk factors. Prev Med 1985;14-312-35.
6. Levine W, Dyer AR, Shekelle RB, et al. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989;42:257-67.
7. Bengtsson C, Lapidus L, Stendahl C, et al. Hyperuricaemia and risk of cardiovascular disease and overall death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988;224:549-55.
8. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biologic and lifestyle characteristics. Am J Epidemiol 1984; 119:653-66.
9. The Coronary Drug Project Research Group. Serum uric acid: its association with other risk factors and with mortality m coronary heart disease. J Chronic Dis 1976;29: 557-69.
10. Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985, 121:11-18.
11. Klein R, Klein BE, Comoni JC, et al. Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease: Evans County, Georgia. Arch Intern Med 1973;132:401-10.
12. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1985;114:413-19.
13. Mustard JF, Murphy EA, Ogryzlo MA, et al. Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J 1963;89:1207-11.
14. Newland H. Hyperuricemia m coronary, cerebral, and peripheral arterial disease: an explanation. Med Hypotheses 1975;1: 152-5.
15. Frolich ED. Uric acid: a risk factor for coronary heart disease. JAMA 1993;270:378-9.
16. Messerli FH, Frolich ED, Dreslinski GR, et al. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980;93:817-21.
17. Facchini F, Chen YDI, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991;266:3008-9.
18. Cappuccio FP, Strazzullo P, Farinaro E, et al. Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 1993;270:354-9.
19. National Center for Health Statistics. Plan and operation of the Health and Nutrition Examination Survey, United States, 1971-1973 Washington, DC: National Center for Health Statistics, reprinted 1979 (Vital and health statistics, Series 1, no. 10a) (DHEW publication no. (HSM)73-1310).
20. Comoni-Huntley JC, Huntley RR, Feldman JJ. Health status and well-being of the elderly. National Health and Nutrition Examination Survey-I Epidemiologic Follow-up Study. New York: Oxford University Press, 1990.
21. Boyle JA, Campbell S, Duncan AM, et al. Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Path 1966;19:501-3.
22. National Center for Health Statistics. HANES I: hematology and clinical chemistry procedures developed or utilized by the Centers for Disease Control, Bureau of Laboratories, 1971-1975. Part 16. Washington, DC: US GPO, August 1979.
23. US Health Care Financing Administration. Commission on Professional and Hospital Activities International Classification of Diseases. Ninth revision, clinical modification. 2nd ed. Washington, DC: US GPO, 1980. (DHHS, publication no. (PHS) 80-1260).
24. Selvin S. Statistical analysis of epidemiologic data. Monographs in epidemiology and biostatistics, Vol 17. New York: Oxford University Press, 1991:310-38.
25. Leaverton PE, Sorlie PD, Kleinman JC, et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis 1987;40:775-84.
26. Goldbourt U, Medalie JH, Herman JB, et al. Serum uric acid: correlations with biochemical, anthropometric, clinical and behavioral parameters in 10, 000 Israeli men. J Chronic Dis 1980;33:435-43.
27. Yano K, Rhoads G, Kagan A. Epidemiology of serum uric acid among 8, 000 Japanese-American men in Hawaii. J Chronic Dis 1977;30:171-84.
28. Wallace RB, Pomrehn P, Heiss G, et al. Alterations in clinical chemistry levels associated with the dyslipoproteinemias. The Lipid Research Clinics Program Prevalence Study. Circulation 1986;73(suppl 1):I62-9.
29. Berkowitz D, Glassman S. Effects of hypertriglyceridemia on urinary uric acid outputs. (Abstract). Circulation 1965; 32(suppl 2).12-13.
30. Cook DG, Shaper AG, Thelle DS, et al. Serum uric acid, serum glucose and diabetes, relationships in a population study. Postgrad Med J 1986;62:1001-6.
31. Gotfredsen A, McNair P, Christiansen C, et al. Renal hypouri- caemia in insulin treated diabetes mellitus. Clin Chim Acta 1982;120:355-61.
32. Reunanen A, Takkunen H, Knekt P, et al. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand 1982, 668(suppl):49-59.
33. Harris EK, Kanofsky P, Shakaiji G, et al. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. H. Estimating biological components of variation. Clin Chem 1979;16:1022-7.
34. Nicholls A, Snaith ML, Scott JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J 1973; 1: 449-51.
35. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990;131:1017-27.
36. Taskinen MR. Strategies for the diagnosis of metabolic syndrome. Curr Opin Lipidol 1993;4:4214-43.
37. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
38. Madans JH, Kleinman JC, Cox CS, et al. Ten years after NHANES I' report of initial follow-up. Public Health Rep 1986;101:465-73.